Literature DB >> 12089266

Performance of CHROMagar selective medium and oxacillin resistance screening agar base for identifying Staphylococcus aureus and detecting methicillin resistance.

Jan Kluytmans1, Arjanne Van Griethuysen, Piet Willemse, Peter Van Keulen.   

Abstract

Two new selective media, oxacillin resistance screening agar base (ORSAB) and CHROMagar Staph aureus (CSA), were evaluated for identification of Staphylococcus aureus and for screening of methicillin resistance by addition of antimicrobial agents to these media. A well-defined collection consisting of 1,140 staphylococci was used. A total of 624 were S. aureus, of which 358 were methicillin susceptible and 266 were methicillin resistant, and 516 were coagulase-negative staphylococci. The methicillin-resistant S. aureus (MRSA) strains were selected based on the results of phage typing; 247 different types were included in the analysis. For identification of S. aureus, both media performed better after 24 h than after 48 h. The sensitivities at 24 h were comparable (CSA, 98.6%; ORSAB, 97.1%), but the specificity of CSA was significantly higher (CSA, 97.1%; ORSAB, 92.1%). For screening of methicillin resistance, antibiotic supplements were added to both media. The sensitivity was lower after 24 h (CSA, 58.6%; ORSAB, 84.2%) and increased significantly after 48 h (CSA, 77.5%; ORSAB, 91.4%). At both time intervals ORSAB was significantly more sensitive than CSA. However, the specificities of both media were high after 24 h (CSA, 99.1%; ORSAB, 98.3%) and decreased significantly after 48 h of incubation (CSA, 94.7%; ORSAB, 95.5%). In conclusion, for identification of S. aureus, CSA is more accurate than ORSAB because of a significantly higher specificity. For screening of MRSA, ORSAB performs better than CSA, but the usefulness in clinical practice is limited because a significant number of strains are not detected.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089266      PMCID: PMC120563          DOI: 10.1128/JCM.40.7.2480-2482.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  New chromogenic identification and detection of Staphylococcus aureus and methicillin-resistant S. aureus.

Authors:  J Merlino; M Leroi; R Bradbury; D Veal; C Harbour
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Salt tolerance of EMRSA-16 and its effect on the sensitivity of screening cultures.

Authors:  E M Jones; K E Bowker; R Cooke; R J Marshall; D S Reeves; A P MacGowan
Journal:  J Hosp Infect       Date:  1997-01       Impact factor: 3.926

3.  First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.

Authors:  S Trakulsomboon; S Danchaivijitr; Y Rongrungruang; C Dhiraputra; W Susaemgrat; T Ito; K Hiramatsu
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

4.  Evaluation of CHROMagar Staph. aureus, a new chromogenic medium, for isolation and presumptive identification of Staphylococcus aureus from human clinical specimens.

Authors:  O Gaillot; M Wetsch; N Fortineau; P Berche
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 5.  Staphylococcus aureus: a well-armed pathogen.

Authors:  G L Archer
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

6.  Rapid slide latex agglutination test for detection of methicillin resistance in Staphylococcus aureus.

Authors:  A van Griethuysen; M Pouw; N van Leeuwen; M Heck; P Willemse; A Buiting; J Kluytmans
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

7.  Sensitivity and specificity of an improved rapid latex agglutination test for identification of methicillin-sensitive and -resistant Staphylococcus aureus isolates.

Authors:  S C Smole; E Aronson; A Durbin; S M Brecher; R D Arbeit
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

8.  Comparison of five tests for identification of Staphylococcus aureus from clinical samples.

Authors:  A Luijendijk; A van Belkum; H Verbrugh; J Kluytmans
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

9.  Performance of the chromogenic medium CHROMagar Staph Aureus and the Staphychrom coagulase test in the detection and identification of Staphylococcus aureus in clinical specimens.

Authors:  A Carricajo; A Treny; N Fonsale; M Bes; M E Reverdy; Y Gille; G Aubert; A M Freydiere
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 10.  Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus.

Authors:  F C Tenover; J W Biddle; M V Lancaster
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

View more
  20 in total

Review 1.  Impact of clinical practice guidelines on the clinical microbiology laboratory.

Authors:  Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

2.  In vitro activity of daptomycin against methicillin-resistant Staphylococcus aureus, including heterogeneously glycopeptide-resistant strains.

Authors:  Bram M W Diederen; Inge van Duijn; Piet Willemse; Jan A J W Kluytmans
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  Performance of CHROMagar MRSA medium for detection of methicillin-resistant Staphylococcus aureus.

Authors:  Bram Diederen; Inge van Duijn; Alex van Belkum; Piet Willemse; Peter van Keulen; Jan Kluytmans
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Evaluation of a new chromogenic medium for isolation and presumptive identification of methicillin-resistant Staphylococcus aureus from human clinical specimens.

Authors:  J Loulergue; C de Gialluly; V Morange; A Holstein; N van der Mee-Marquet; R Quentin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-06       Impact factor: 3.267

5.  Performance of MRSA ID, a new chromogenic medium for detection of methicillin-resistant Staphylococcus aureus.

Authors:  Bram M W Diederen; Marie-Louise van Leest; Inge van Duijn; Piet Willemse; Peter H J van Keulen; Jan A J W Kluytmans
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

6.  Evaluation of a new chromogenic medium, MRSA select, for detection of methicillin-resistant Staphylococcus aureus.

Authors:  Lisa Louie; Deirdre Soares; Helen Meaney; Mary Vearncombe; Andrew E Simor
Journal:  J Clin Microbiol       Date:  2006-10-18       Impact factor: 5.948

7.  Evaluation of two chromogenic agar media for recovery and identification of Staphylococcus aureus small-colony variants.

Authors:  Frank Kipp; Barbara C Kahl; Karsten Becker; Ellen J Baron; Richard A Proctor; Georg Peters; Christof von Eiff
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

8.  Performance of a new chromogenic medium, BBL CHROMagar MRSA II (BD), for detection of methicillin-resistant Staphylococcus aureus in screening samples.

Authors:  Kristien Van Vaerenbergh; Reinoud Cartuyvels; Guy Coppens; Johan Frans; Anne-Marie Van den Abeele; Hans De Beenhouwer
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

9.  Evaluation of S. aureus ID, a new chromogenic agar medium for detection of Staphylococcus aureus.

Authors:  John D Perry; Claire Rennison; Lynne A Butterworth; Andrew L J Hopley; F Kate Gould
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

10.  Performance of Oxoid Brilliance MRSA medium for detection of methicillin-resistant Staphylococcus aureus: an in vitro study.

Authors:  E Verkade; S Elberts; C Verhulst; J Kluytmans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-09-11       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.